On guard - Activating NK cell receptors

Nature Immunology

Volumn 2, Issue 1, 2001, Pages 23-27

  Lanier, Lewis L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CD28 ANTIGEN; HCST PROTEIN, HUMAN; HCST PROTEIN, MOUSE; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; SH2D1A PROTEIN, HUMAN; SH2D1A PROTEIN, MOUSE; SIGNAL PEPTIDE;

ANIMAL; BIOLOGICAL MODEL; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; NATURAL KILLER CELL; REVIEW; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIGENS, CD28; CARRIER PROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KILLER CELLS, NATURAL; MEMBRANE PROTEINS; MICE; MODELS, BIOLOGICAL; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 0035235045     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/83130     Document Type: Review

References (100)

1. Ravetch, J.V. & Lanier, L. L. Immune inhibitory receptors. Science 290, 84-89 (2000).
2. Long, E. O. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17, 875-904 (1999).
3. Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J. & Ploegh, H. L. Viral subversion of the immune system. Annu. Rev. Immunol. 18, 861-926 (2000).
4. Algarra, I., Cabrera, T. & Garrido, F. The HLA crossroad in tumor immunology. Human Immunol. 61, 65-73 (2000).
5. Lanier, L L, Corliss, B. & Phillips, J. H. Arousal and inhibition of human NK cells. Immunol. Rev. 155, 145-154 (1997).
6. Reth, M. Antigen receptor tail clue. Nature 338, 383-384 (1989).
7. Isakov, N. Role of immunoreceptor tyrosine-based activation motif in signal transduction from antigen and Fc receptors. Adv. Immunol. 69, 183-247 (1998).
8. Lanier, L. L, Yu, G. & Phillips, J. H. Analysis of FcgRIII (CD16) membrane expression and association with CD3ζ and FceRI-γ by site-directed mutation. J. Immunol. 146, 1571-1576 (1991).
9. Wu, J., Cherwinski, H., Spies, T., Phillips, J. H. & Lanier, L. L. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J. Exp. Med. 192, 1059-1068 (2000).
10. Lanier, L. L., Yu, G. & Phillips, J. H. Co-association of CD3ζ with a receptor (CD16) for IgG Fc on human natural killer cells. Nature 342, 803-805 (1989).
11. Kurosaki, T. & Ravetch, J.V. A single amino acid in the glycosyl phosphatidylinositol attachment domain determines the membrane topology of FcγRIII. Nature 342, 805-807 (1989).
12. Perussia, B. Signaling for cytotoxicity. Nature Immunol. 1, 372-374 (2000).
13. Perussia, B. et al. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions II. Studies of B73.1 antibody-antigen interaction on the lymphocyte membrane. J. Immunol. 130, 2142-2148 (1983).
14. Lanier, L. L., Le, A. M., Phillips, J. H., Warner, N. L. & Babcock, G. F. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J. Immunol. 131, 1789-1796 (1983).
15. Anegon, I., Cuturi, M. C., Trinchieri, G. & Perussia, B. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptors (CD25) and lymphokine genes and expression of their products in human natural killer cells. J. Exp. Med. 167, 452-472 (1988).
16. Azzoni, L., Anegon, I., Calabretta, B. & Perussia, B. Ligand binding to FcgR induces c-myc-dependent apoptosis in IL-2-stimulated NK cells. J. Immunol. 154, 491-499 (1995).
17. Ortaldo, J. R., Mason, A. T. & O'Shea, J. J. Receptor-induced death in human natural killer cells: Involvement of CD16. J. Exp. Med. 181, 339-344 (1995).
18. Takai, T., Li, M., Sylvestre, D., Clynes, R. & Ravetch, J.V. FcR γ chain deletion results in pleiotropic effector cell defects. Cell 76, 519-529 (1994).
19. Clynes, R. A., Towers, T. L., Presta, L G. & Ravetch, J.V. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nature Med. 6, 443-446 (2000).
20. +T cells. J. Exp. Med. 186, 1957-1963 (1997).
21. Pessino, A. et al. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J. Exp. Med. 188, 953-960 (1998).
22. Pende, D. et al. Identification and molecular characterization of NKP30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 190, 1505-1516 (1999).
23. Tomasello, E. et al. Association of signal-regulatory proteins beta with KARAP/DAP-12. Eur. J. Immunol. 30, 2147-2156 (2000).
24. Colucci, F. et al. Redundant role of the Syk protein tyrosine kinase in mouse NK cell differentiation. J. Immunol. 163, 1769-1774 (1999).
25. Lanier, L. L., Corliss, B. C., Wu, J., Leong, C. & Phillips, J. H. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391, 703-707 (1998).
26. Olcese, L. et al. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J. Immunol. 158, 5083-5086 (1997).
27. Lanier, L. L., Corliss, B., Wu, J. & Phillips, J. H. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 8, 693-701 (1998).
28. Smith, K. M., Wu, J., Bakker, A. B. H., Phillips, J. H. & Lanier, L L L/49D and Ly49H associate with mouse DAP12 and form activating receptors. J. Immunol. 161, 7-10 (1998).
29. Vitale, M. et al. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187, 2065-2072 (1998).
30. Bakker, A. B., Baker, E., Sutherland, G. R., Phillips, J. H. & Lanier, L L. Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. Proc. Natl Acad. Sci. USA 96, 9792-9796 (1999).
31. Dietrich, J., Cella, M., Seiffert, M., Buhring, H. J. & Colonna, M. Cutting edge: signal-regulatory protein β1 is a DAP12-associated activating receptor expressed in myeloid cells. J. Immunol. 164, 9-12 (2000).
32. Bouchon, A., Dietrich, J. & Colonna, M. Cutting edge: inflammatory responses can Be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J. Immunol. 164, 4991-4995 (2000).
33. McVicar, D.W. et al. DAP12-mediated signal transduction in natural killer cells. A dominant role for the syk protein-tyrosine kinase. J. Biol. Chem. 273, 32934-32942 (1998).
34. Braud, V. M. et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B, and C. Nature 391, 795-798 (1998).
35. Vance, R. E., Jamieson, A. M. & Raulet, D. H. Recognition of the Class lb molecule Qa-lb by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. J. Exp. Med. 190, 1801-1812 (1999).
36. George, T. C., Ortaldo, J. R., Lemieux, S., Kumar, V. & Bennett, M. Tolerance and Alloreactivity of the Ly49D Subset of Murine NK Cells. J. Immunol. 163, 1859-1867 (1999).
37. Idris, A. H. et al. The natural killer gene complex genetic locus Chok encodes Ly-49D, it target recognition receptor that activates natural killing. Proc. Natl. Acad. Sci. USA 96, 6330-6335 (1999).
38. Nakamura, M. C. et al. Natural killing of xenogeneic cells mediated by the mouse Ly-49D receptor. J. Immunol. 163, 4694-700 (1999).
39. Winter, C. C., Gumperz, J. E., Parham, P., Long, E. O. & Wagtmann, N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J. Immunol. 161, 571-577 (1993).
40. Valés-Gómez, M., Reyburn, H. T., Erskine, R. A., Lopez-Botet, M. & Strominger, J. L Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J. 18, 4250-4260 (1999).
41. Tomasello, E. et al. Combined Natural Killer Cell and Dendritic Cell Functional Deficiency in KARAP/DAP12 Loss-of-Function Mutant Mice. Immunity 13, 355-364 (2000).
42. Bakker, A.B.H. et al. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13, 345-353 (2000).
43. Paloneva, J. et al. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nature Genet. 25, 357-361 (2000).
44. Jiang, K. et al. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nature Immunol. 1, 419-425 (2000).
45. Wu, J. et al. An activating receptor complex on natural killer and T cells formed by NKG2D and DAP10. Science 285, 730-732 (1999).
46. Houchins, J. P., Yabe, T., McSherry, C. & Bach, F. H. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J. Exp. Med. 173, 1017-1020 (1991).
47. Songyang, Z. et al. SH2 domains recognize specific phosphopeptide sequences. Cell 72, 767-778 (1996).
48. Chang, C. et al. Cutting edge: KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties. J. Immunol. 163, 4651-4654 (1999).
49. Bauer, S. et al. Activation of natural killer cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727-730 (1999).
50. Berg, S. F., Dissen, E., Westgaard, I. H. & Fossum, S. Molecular characterization of rat NKR-P2, a lectin-like receptor expressed by NK cells and resting T cells. Int. Immunol. 10, 379-385 (1998).
51. Ho, E. L. et al. Murine Nkg2d and Cd94 are clustered within the natural killer complex and are expressed independently in natural killer cells. Proc. Natl Acad. Sci. USA 95, 6320-6325 (1998).
52. Bahram, S., Bresnahan, M., Geraghty, D. E. & Spies, T. A second lineage of mammalian major histocompatibility complex class I genes. Proc. Natl Acad. Sci. USA 91, 6259-6263 (1994).
53. Li, P. et al. Crystal structure of the MHC class I homolog MIC-A, a γδ T cell ligand. Immunity 10, 577-584 (1999).
54. Groh, V. et al. Cell stress-regulated human major histocompacibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl Acad. Sci. USA 93, 12445-12450 (1996).
55. Groh, V. et al. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl Acad. Sci. USA 96, 6879-6884 (1999).
56. Nomura, M. et al. Genomic structures and characterization of Rae1 family members encoding GPI-anchored cell surface proteins and expressed predominantly in embryonic mouse brain. J. Biochem. 120, 987-995 (1996).
57. Nomura, M., Takihara, Y. & Shimada, K. Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: one of the early inducible clones encodes a novel protein sharing several highly homologous regions with a Drosophila polyhomeotic protein. Differentiation 57, 39-50 (1994).
58. Malarkannan, S. et al. The molecular and functional characterization of a dominant minor H antigen, H60. J. Immunol. 161, 3501-3509 (1998).
59. Cerwenka, A. et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12, 721-727 (2000).
60. Diefenbach, A., Jamieson, A.M., Liu, S.D., Shastri, N. & Raulet, D.H. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nature Immunol. 1, 119-126 (2000).
61. Chalupny, J. et al. Soluble forms of the novel MHC class I-related molecules, ULBP1 and ULBP2, bind to and functionally activate NK cells. FASEB J. 14, 1018 (2000).
62. Lenschow, D.J., Walunas, T.L. & Bluestone, J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233-258 (1996).
63. Chambers, C.A. & Allison, J.P. Costimulatory regulation of T cell function. Curr. Opin. Cell. Biol. 11, 203-210 (1999).
64. Prasad, K.V. et al. T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr (P)-Met-Xaa-Met motif. Proc. Natl Acad. Sci. USA 91, 2834-2838 (1994).
65. Truitt, K. E., Hicks, C. M. & Imboden, J. B. Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol 3-kinase in Jurkat T cells. J. Exp. Med. 179, 1071-1076 (1994).
66. Pages, F. et al. Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling. Nature 369, 3327-3329 (1994).
67. Stein, P. H., Fraser, J. D. & Weiss, A. The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3′-kinase. Mol. Cell. Biol. 14, 3392-3402 (1994).
68. Truitt, K. E. et al. CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase. J. Immunol. 155, 4702-4710 (1995).
69. Ni, H.-T., Deeths, M. J. & Mescher, M. F. Phosphatidylinositol 3 kinase activity is not essential for B7-1-mediated costimulation of proliferation or development of cytotoxicity in murine T cells. J. Immunol. 157, 2243-2246 (1996).
70. Cai, Y.-C. et al. Selective CD28 pYMNM mutations implicate phosphatidylinositol 3-kinase in CD86-CD28-mediated costimulation. Immunity 3, 417-426 (1995).
71. Nandi, D., Gross, J.A. & Allison, J.P. CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. J. Immunol. 152, 3361-3369 (1994).
72. Heldhof, A.B. et al. Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity. Cancer Res. 55, 2730-2733 (1995).
73. Chambers, B. J., Salcedo, M. & Ljunggren, H.-G. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 5, 311-317 (1996).
74. Hunter, C. A. et al. The role of the CD28/B7 interaction in regulation of NK cell responses during infection with Toxoplasma gondii. J. Immunol. 158, 2285-2293 (1997).
75. Azuma, M., Cayabyab, M., Buck, D., Phillips, J. H. & Lanier, L L Involvement of CD28 in major histocompatibility complex-unrestricted cytotoxicity mediated by a human NK leukemia cell line. J. Immunol. 149, 1115-1123 (1992).
76. Lanier, L. L. et al. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL J. Immunol. 154, 97-105 (1995).
77. Galea-Lauri, J. et al. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells. J. Immunol. 163, 62-70 (1999).
78. Garni-Wagner, B.A., Purohit, A., Mathew, P.A., Bennett, M. & Kumar, K. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J. Immunol. 151, 60-70 (1993).
79. Mathew, P.A. et al. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J. Immunol. 151, 5328-5337 (1993).
80. Poy, F. et al. Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition. Mol. Cell 4, 555-561 (1999).
81. Cocks, B. G. et al. A novel receptor involved in T-cell activation. Nature 376, 260-263 (1995).
82. Sayos, J. et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395, 462-469 (1998).
83. Nichols, K. E. et al. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl Acad Sci. USA 95, 13765-13770 (1998).
84. Seemayer, T.A. et al. X-linked lymphoproliferative disease: Twenty-five years after the discovery. Pediatr. Res. 38, 471-478 (1999).
85. Brown, M. H. et al. 2B4, the Natural Killer and T Cell Immunoglobulin Superfamily Surface Protein, Is a Ligand for CD48. J. Exp. Med 188, 2083-2090 (1998).
86. Latchman, Y., McKay, P. F. & Reiser, H. Identification of the 2B4 molecule as a counter-receptor for CD48. J. Immunol. 161, 5809-5812 (1998).
87. Yokoyama, S. et al. Expression of the BLAST-1 activation/adhesion molecule and its identification as CD48. J. Immunol. 146, 2192-2200 (1991).
88. Klaman, L. D. & Thorley-Lawson, D.A. Characterization of the CD48 gene demonstrates a positive element that is specific to Epstein-Barr virus-immortalized B-cell lines and contains an essential NF-κB site. J. Virol. 69, 871-881 (1995).
89. Valiante, N. M. & Trinchieri, G. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J. Exp. Med. 178, 1397-1406 (1993).
90. Tangye, S. G., Phillips, J. H., Lanier, L. L. & Nichols, K. E. Cutting edge: functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J. Immunol. 165, 2932-2936 (2000).
91. Sivori, S. et al. 2B4 functions as a co-receptor in human NK cell activation. Eur. J. Immunol. 30, 787-793 (2000).
92. Nakajima, H., Cella, M., Langen, H., Friedlein, A. & Colonna, M. Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur. J. Immunol. 29, 1676-1683 (1999).
93. Tangye, S. G. et al. Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J. Immunol. 162, 6981-6985 (1999).
94. Watzl, C., Stebbins, C. C. & Long, E. O. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244). J. Immunol. 165, 3545-3543 (2000).
95. Kubin, M. Z. et al. Molecular cloning and biological characterization of NK cell activation- inducing ligand, a counterstructure for CD48. Eur. J. Immunol. 29, 3466-3477 (1999).
96. Parolini, S. et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J. Exp. Med 192, 337-346 (2000).
97. Benoit, L., Wang, X., Pabst, H. F., Dutz, J. & Tan, R. Defective NK cell activation in X-linked lymphoproliferative disease. J. Immunol. 165, 3549-3553 (2000).
98. Nakajima, H. et al. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. Eur. J. Immunol. 30, 3309-3318 (2000).
99. +T cell activation. Proc. Natl Acad Sci USA 96, 1019-1023 (1999).
100. Schuhmachers, G. et al. Activation of murine epidermal γδT cells through surface 2B4. Eur. J. Immunol. 25, 1117-1120 (1995).